Compare IPWR & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPWR | ELUT |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.1M | 48.3M |
| IPO Year | 2013 | 2020 |
| Metric | IPWR | ELUT |
|---|---|---|
| Price | $4.19 | $1.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.75 | $6.00 |
| AVG Volume (30 Days) | ★ 230.9K | 66.7K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | $2,603.56 | N/A |
| Revenue Next Year | $1,800.00 | $10.83 |
| P/E Ratio | ★ N/A | $1.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.62 | $0.50 |
| 52 Week High | $6.90 | $2.60 |
| Indicator | IPWR | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 61.02 | 41.16 |
| Support Level | $3.77 | $1.00 |
| Resistance Level | $4.35 | $1.16 |
| Average True Range (ATR) | 0.51 | 0.06 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 54.55 | 2.94 |
Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.